Overall, our data provide evidence that cellular senescence may be an underlying pathogenic process common among tauopathies, which opens a new field of investigative research and offers a potential druggable target to treat the >20 tau‐associated neurodegenerative diseases. Here, MAPT is linked to neurodegenerative disease.